Related Experiment Videos
Apoptosis in oncology
1International Joint Cancer Institute, The Second Military Medical University, Shanghai, China.
Abstract:
Apoptosis is a complex process involving a large array of genes and mutation of any of these genes may lead to malignancy formation. Re-acquirement of FasL by tumor cells may enable them to evade the surveillance of immune system and thus contributes to the growth of tumor. Apart from traditional therapies, inducing apoptosis of tumor cell by new methods employing death receptor ligands and making use of Fas counterattack is also being developed.
Insights
Tumor cells can evade immune surveillance by re-acquiring Fas Ligand (FasL), promoting tumor growth. New cancer therapies are exploring ways to induce tumor cell apoptosis using death receptor ligands and Fas counterattack strategies.
Area of Science:
- Molecular Biology
- Immunology
- Oncology
Background:
- Apoptosis is a crucial biological process regulated by numerous genes.
- Mutations in apoptosis-related genes can lead to the development of malignancies.
- Tumor cells can acquire Fas Ligand (FasL) to evade immune system surveillance, facilitating tumor progression.
Purpose of the Study:
- To investigate the role of FasL in tumor immune evasion.
- To explore novel therapeutic strategies for inducing tumor cell apoptosis.
Main Methods:
- Analysis of gene expression related to apoptosis.
- Investigating the mechanism of FasL re-acquirement by tumor cells.
- Developing novel therapeutic approaches utilizing death receptor ligands.
Main Results:
- Tumor cells expressing FasL can effectively escape immune surveillance.
- Fas counterattack strategies show potential in inducing tumor cell death.
Conclusions:
- Understanding apoptosis pathways is critical for cancer development.
- Targeting FasL and employing Fas counterattack are promising avenues for novel cancer therapies.